Transchem logo

Transchem financials: balance sheet, profit and loss, cash flow

BSE: 500422Pharmaceuticals & BiotechnologySmall Cap

Transchem Limited. · Face value ₹10 · Listed Jun 1993
Last close ₹407.40down ₹0.20 (0.05%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹407.60.

30 Oct: open ₹418.00, high ₹418.00, low ₹400.00

52-week range of traded prices to 30 Oct 2026
₹63.01Low, 13 Nov 2025₹433.00High, 30 Sep 2026
Market cap
₹499 Cr2,295th largest listed
P/E
74.17
P/B
5.97
Dividend yield
Nonein the last 12 months
ROE
8.3%
ROCE
−4.9%
Debt to equity
0.00
Volume, BSE
10,554

Transchem's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them. It had no borrowings at 31 Mar 2026.

10 years at a glance

₹ crore, years to March.Transchem annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
1.8−0.4Mar 172.1−1.2Mar 1800.30Mar 1900.40Mar 200240Mar 2102.90Mar 2201.20Mar 230.44.20Mar 242.65.20Mar 2504.30Mar 26
Peak revenue ₹2.63 Cr, year to Mar 2025; lowest ₹0.00 Cr, year to Mar 2019A loss in 2 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
1,025.2%−423.4%−423.4%−55.7%−23.2%−56.4%1,025.2%198.7%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs−1.2
  3. Other expenses−2.4
  4. Operating profit−3.6
  5. Depreciation0.0
  6. Other income+9.3
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax5.6
  10. Tax−1.3
  11. Net profit4.3

What the company owns

  • Plant, investments and other assets₹43 Cr
  • Cash and bank₹42 Cr
  • Receivables₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹84 Cr
  • Other liabilities₹4 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Transchem quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 5 MayJun 2026Twelve monthsFiled 10 Aug
Revenue from operations1.82.10.00.00.00.00.00.42.60.00.0
––1.41.41.92.71.72.14.13.64.1
Materials and goods bought––0.00.00.00.00.00.42.60.00.0
Employee costs––0.50.70.80.80.90.90.71.21.3
Other expenses––0.90.71.11.90.80.80.82.42.7
Operating profit before depreciation––−1.4−1.4−1.9−2.7−1.7−1.7−1.5−3.6−4.1
Operating margin–––––––−423.4%−55.7%––
Materials, % of revenue–––––––97.6%99.2%––
Employee costs, % of revenue–––––––219.1%25.5%––
Other expenses, % of revenue–––––––206.7%31.0%––
Depreciation and amortisation1.01.00.80.60.10.00.00.00.00.00.1
Operating profit after depreciation––−2.2−2.0−2.1−2.8−1.7−1.7−1.5−3.7−4.1
Other income1.82.12.92.826.86.74.27.48.59.312.7
Finance costs0.00.00.00.00.00.00.00.00.00.00.0
Profit before one-off items and tax−0.1−0.60.80.824.83.92.55.77.15.68.6
One-off items−0.4–0.00.00.00.00.00.00.00.00.0
Profit before tax−0.4−0.60.80.824.83.92.55.77.15.68.6
–0.60.50.40.61.01.31.41.81.31.9
Net profit−0.4−1.20.30.424.22.91.24.25.24.36.7
Other comprehensive income––0.9−1.62.00.5−1.75.6−1.60.00.0
Total comprehensive income––1.2−1.226.23.4−0.59.83.74.36.7
Net margin−23.2%−56.4%–––––1,025.2%198.7%––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2017 and Mar 2018: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 5 May
38.036.862.966.365.875.679.383.6
Share capital12.212.212.212.212.212.212.212.2
Reserves25.724.550.754.153.663.467.171.3
Borrowings0.00.00.00.00.00.00.00.0
0.20.10.30.30.10.50.34.0
0.20.20.20.20.30.20.10.2
Total assets38.437.163.466.866.276.379.787.7
10.27.48.88.98.39.02.12.2
28.229.754.657.957.967.377.685.5
Net debt−16.3−16.5−11.7−34.2−34.5−0.3−42.3−42.4
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 5 May
−27.721.91.2−39.336.0−1.6
−27.023.42.3−38.038.2−0.4
−29.519.5−0.2−43.631.7−5.0
Receivables0.00.00.0−0.4−2.30.0
Inventories0.0−0.10.20.00.00.0
Payables0.00.00.00.00.10.0
Other working capital−29.519.6−0.3−43.233.8−5.0
Tax paid−0.7−1.4−1.1−1.3−2.2−1.2
Capital spending0.10.00.00.00.00.0
Free cash flow−27.821.91.2−39.336.0−1.6
23.10.6−0.95.16.01.7
Cash from financing0.00.00.00.00.00.0
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash−4.722.50.3−34.242.00.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 5 May
Earnings per share−₹0.34−₹0.97₹0.25₹0.33₹19.73₹2.34₹1.01₹3.43₹4.27₹3.51
Diluted earnings per share−₹0.34−₹0.97₹0.25₹0.33₹19.73₹2.34₹1.01₹3.43₹4.27₹3.51
Book value per share––₹31.03₹29.55₹51.42₹54.17₹53.79₹61.80₹64.80₹68.28
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)274029202027233441199

Ratios

Standalone, years to March.Transchem PE ratio and valuation

RatioMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 5 May
Revenue growth18.8%−100.0%–––––541.6%−100.0%
Net profit growth––34.2%5,797.5%−88.1%−56.9%239.8%24.3%−17.8%
Earnings per share growth––32.0%5,878.8%−88.1%−56.8%239.6%24.5%−17.8%
––––––5.9%6.7%–
–––––––0.8 pts–
From the net margin–––––––−4.8 pts–
From asset turnover–––––––5.6 pts–
From borrowing–––––––0.0 pts–
Return on capital employed–−5.7%−5.3%−3.3%−4.2%−2.6%−2.3%−1.9%−4.4%
Cash conversion–––−114.8%763.9%98.6%−935.1%688.9%−36.5%
Debt to equity–0.000.000.000.000.000.000.000.00
Receivable days––––––365376–
Inventory days––––––00–
Payable days––––––019–
Cash conversion cycle, days––––––365357–
Working capital days––––––59,2304,857–
Asset turnover–0.000.000.000.000.000.010.030.00
Assets per rupee of net worth–1.011.011.011.011.011.011.011.03
Sales per rupee of plant–0.000.000.000.000.004.8254.690.00
Capital spending to depreciation–––0.660.000.000.370.472.52
Plant being built, % of plant in use–––0.0%0.0%0.0%0.0%––
Interest cover is left blank for the years to Mar 2019, Mar 2020, Mar 2021, Mar 2022, Mar 2023 and Mar 2024: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.1%
Measure5 years3 years
Profit growth, yearly rate−29.2%51.4%
Return on equity, average–6.3%
Return on capital employed, average−3.1%−2.8%
Operating margin, average–−239.5%
Net margin, average–611.9%
Asset turnover, average0.010.01
Cash conversion cycle, days, average–361
Debt to equity, average0.000.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations18.3−4.9−1.6
Cash from investing12.512.81.7
Cash from financing0.00.00.0
Capital spending0.00.00.0
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid0.00.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––––7–
Altman Z-scorePublished threshold 1.8146.3641.9629.0933.8738.3833.1462.2931.22
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––57.34−30.161.4453.86−47.165.02
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––−0.16−1.95−0.20−0.35
Receivables growth less revenue growthOur threshold 0 percentage points––––––19.1779.42
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––171.22−37.75–
Assets under construction, years of additionsOur threshold 2 years of additions–––––0.00––
Effective tax ratePublished threshold 17.16 per cent60.6448.332.5026.6150.6025.6426.0123.41
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––−10.467.752.02−5.452.18
A threshold marked as ours has no published figure; it is the line we read the check against.